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 Abstract
The imaging analytical capabilities of laser scanning cytometer (LSC) have been used to
assess morphological features considered to be typical of the senescent phenotype. The
characteristic ‘‘flattening’’ of senescent cells was reflected by the decline in the density of
staining (intensity of maximal pixel) of DNA-associated fluorescence [4,6-diamidino-2-
phenylindole (DAPI)] paralleled by an increase in nuclear size (area). The decrease in ra-
tio of maximal pixel to nuclear area was even more sensitive senescence biomarker than
the change in maximal pixel or nuclear area, each alone. The saturation cell density at
plateau phase of growth recorded by LSC was found to be dramatically decreased in cul-
tures of senescent cells, thereby also serving as an additional marker. The induction of
cyclin dependent kinase inhibitors p21
WAF1 and p27
KIP1 and cH2AX and activation of
ATM markers of DNA damage response were measured in parallel with DNA/DAPI max-
imal pixel and nuclear area. These biomarker indices were expressed in quantitative terms
by reporting them as a fraction of the respective controls. The effect of treatment of A549
and WI-38 cells with different concentrations of mitoxantrone (Mxt) and trichostatin A
for various time periods was studied to assess the degree (depth) of cell senescence. Also
assessed was the effect of 2-deoxy-D-glucose, the agent attenuating metabolic cell activity,
on the depth of senescence induced by Mxt. A relationship between the ability of cells to
synthesize RNA (incorporate 5-ethynyluridine) that leads to growth imbalance and
induction of cell senescence was also studied. The data show that morphometric analysis
of cellular attributes by LSC offers an attractive tool to detect cell senescence and measure
its degree particularly in assessing effects of the factors that enhance or attenuate this pro-
cess. This methodology is of importance in light of the evidence that cellular senescence
is not only a biological process that is fundamental for organismal aging but also impedes
formation of induced-pluripotent stem cells providing the barrier for neoplastic transfor-
mation and is the major mechanism of induction of reproductive cell death during treat-
ment of solid tumors. ' 2010 International Society for Advancement of Cytometry
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THE goal of treatment of malignancies is containment of tumor growth either by
prompt killing of the targeted tumor cells or by elimination of their reproductive
potential. Apoptosis is frequently the mode of cell death on treatment with most
antitumor modalities. Because induction of apoptosis involves complex interactions
between many signaling pathways and arrangement of the highly sophisticated execu-
tion machinery of cell death, diverse antitumor strategies have been proposed to
affect these interactions to preferentially kill tumor cells while sparing normal cells
(1–5). Although cells in certain malignancies, particularly leukemias, are prone to
undergo apoptosis, in many solid tumors, the mechanism of treatment-induced sup-
pression of growth relies on irreversible impairment of cell reproductive capacity
(‘‘reproductive death’’), which is often defined as ‘‘senescence-like growth arrest,’’
‘‘accelerated senescence,’’ ‘‘premature senescence,’’ or ‘‘drug- or radiation-induced
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pression of certain oncogenes may also lead to proliferation
arrest characterized by senescence-like features. The loss of
reproductive potential of cells undergoing malignant transfor-
mation, whether through induction of apoptosis or senes-
cence, plays an important role as one of the barriers to tumor
development (7,11–16).
Identification of senescent cells relies on several markers.
The most characteristic are morphological alterations (17,18).
Senescent cells are described as having low saturation density at
the plateau phase of growth, ‘‘flattened’’ appearance, enlarged,
often irregular nuclei, and cytoplasmic granularities. An
increase in cellular size is paralleled by an increase in nuclear
and nucleolar size. There are numerous vacuoles in the cyto-
plasm, increased number of cytoplasmic microfilaments, the
presence of large lysosomal bodies, and prominent Golgi appa-
ratus (17–19). The increased lysosome mass is likely due to the
presence of secondary lysosomes containing indigestible materi-
als such as lipofuscins (18,20–22). Gross abnormalities are char-
acteristics of nuclear chromatin of senescent cells. The most
prominent is the presence of senescence-associated heterochro-
matic foci (SAHF), which are abundant in histone H3 modified
at lysine 9 (K9M H3) and its binding partner heterochromatin
protein 1 (HP1) (23–25). However, it should be pointed out
that the presence of SAHF while observed in senescent WI-38
and IMR90 cells was not apparent in some other cell types (26).
A variety of molecular markers characterize cells under-
going senescence. The suppressed proliferation of senescent
cells is, to a large degree, induced by overexpression of inhibi-
tors of cyclin dependent kinases (CDKs) p21
WAF1, p16
INK4A,
and/or p27
KIP1 that may or may not be mediated by the tumor
suppressor p53 (14,27–33). There is also persistent expression
of markers of DNA damage response, particularly cH2AX
(34–36). However, it should be stressed that among all bio-
markers the most specific to senescent cells are: (i) the charac-
teristic changes in cell morphology and (ii) the induction of
senescence-associated b-galactosidase activity; the latter is
considered to be the hallmark of cell senescence (37,38).
In this study, we have examined whether the senescence-
associated alterations in cell morphology can be quantitatively
assessed by laser scanning cytometer (LSC). LSC is the micro-
scope-based analytical instrument that offers the combined
advantages of flow cytometry and image analysis (39–41). It can
analyze 100 cells per second, record a large number of the
measuredparametersincluding cellmorphometricdata,and pre-
serve images of the analyzed cells (41). Our present data reveal
that the very simple analysis of the nuclear size (area) combined
with the intensity of maximal pixel of DNA associated fluores-
cence on its staining with 4,6-diamidino-2-phenylindole (DAPI)
provide a convenient marker of the degree of cell senescence. The
use of this marker made it possible to study the effects of several
factors modulating the propensity of different cell types to
undergo senescence, such as suppression of metabolic activity by
2-deoxy-D-glucose (2dG), capacity to continue cell growth
(synthesize RNA), and importance of cell cycle phase. Using mul-
tiparameter analysis, we were able to correlate the induction of se-
nescence with the expression of p21
WAF1 and parameters of DNA
damage response such as phosphorylation of H2AX and activa-
tion of ataxia telangiectasia mutated kinase (ATM).
MATERIALS AND METHODS
Cells, Cell Treatment
Human pulmonary adenocarcinoma A549 cells were pur-
chased from American Type Culture Collection (ATCC #CCL-
185, Manassas, VA). The cells were cultured in Ham’s F12K me-
dium with 2 mM L-glutamine adjusted to contain 1.5 g/l sodium
bicarbonate (GIBCO/Invitrogen, Carlsbad, CA) and supplemen-
t e dw i t h1 0 %f e t a lb o v i n es e r u m( F B S ;G I B C O / I n v i t r o g e n ) .W I -
3 8f i b r o b l a s t sw e r ea l s of r o mA T C Ca n dw e r eg r o w ni nM E M
Eagle–Earle medium containing essential and nonessential amino
acids, 2mM L-glutamine, and 10% FBS. Dual-chambered slides
(Nunc Lab-Tek II Fisher Scientific, Pittsburgh, PA) were seeded
with 1 ml of 10
5 cells/ml cell suspension per chamber 48 h before
exposure. All incubations were performed at 378C in a humidified
atmosphere of 5% CO2 in air. Trichostatin A (TSA) and 2dG were
from Sigma–Aldrich (St. Louis, MO). Mitoxantrone (Mxt) was
obtained from Lederle Laboratories (Pearl River, NY). Drug con-
centrations and other details are given in figure legends. At the
end of the incubation, medium from each chamber was carefully
aspirated and 1 ml of 1% fresh methanol-free formaldehyde in
13 phosphate buffered saline (PBS) was added to each chamber
and the cells fixed by gently rocking the slides at room tempera-
ture for 15 min. Following aspiration of the fixative, the chamber
slides were disassembled and the slides submerged in 70% ethanol.
The fixed slides were stored at 48C before analysis. The incorpora-
tion of the RNA precursor 5-ethynyluridine (EU) was detected by
the ‘‘click’’ methodology (42), using the protocol and the reagents
provided by Invitrogen/Molecular Probes (Carlsbad, CA).
Immunocytochemical Detection of p21
WAF1, p16
KIP1,
Phosphorylated Histone H2AX (cH2AX),
and Activated ATM
After fixation, the cells were washed twice in PBS and trea-
t e do ns l i d e sw i t h0 . 1 %T r i t o nX - 1 0 0( S i g m a )i nP B Sf o r1 5m i n ,
a n dt h e ni na1 %( w / v )s o l u t i o no fb o v i n es e r u ma l b u m i n( B S A ;
Sigma) in PBS for 30 min to suppress nonspecific antibody (Ab)
binding. The cells were then incubated in a 100 llv o l u m eo f1 %
BSA containing 1:100 dilution of p21
WAF1 or p16
KIP1 Ab (Cell
Signaling, Danvers, MA) or 1:200 dilution of phosphospecific
(Ser139) cH2AX mAb (Biolegend, San Diego, CA) or 1:100 dilu-
tion of phosphospecific (Ser1981) ATM mAb (Cell Signaling) for
1.5 h at room temperature or overnight at 48C. The secondary
fluorochrome-tagged Abs used were either Alexa Fluor 488
tagged Ab (Invitrogen/Molecular Probes, at 1:100 dilution) or
Alexa Fluor 633 Ab (Invitrogen/Molecular Probes, at 1:100 dilu-
tion). Before fluorescence measurement on the LSC, the cells
were counterstained with 2.8 lg/ml DAPI (Sigma) in PBS for 15
min. Other details of cell incubations with the primary and sec-
ondary Ab were presented before (43–45).
Measurement of Cell Fluorescence by LSC
Cellular green or far red immunofluorescence (IF) repre-
senting binding of the respective phosphospecific Abs and the
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LSC (iCys
1 Research Imaging Cytometer; CompuCyte, West-
wood, MA) and standard filter settings; fluorescence was
excited with 488 nm argon, helium–neon (633 nm), and violet
(405 nm) lasers (39–41). The intensities of maximal pixel and
integrated fluorescence were measured and recorded for each
cell. At least 3,000 cells were measured per sample. The stand-
ard deviation was estimated based on Poisson distribution of
cell populations. Other details are given in figure legends.
RESULTS
Different approaches have been used to induce senescence
of A549 or WI-38 cells. In one set of experiments, senescence
of human lung carcinoma A549 cells was induced by their ex-
posure to low concentration (2 nM) of the DNA topoisomer-
ase II inhibitor Mxt, an anthracenedione that binds to DNA
by intercalation (46). Following growth for 48 h in the pre-
sence of Mxt, cell morphology was altered as the cells acquired
features characteristic of senescence. The LSC analysis of the
cell density on slides on which cells were growing revealed that
the saturation density at confluence was distinctly lower com-
pared with the control cells growing in parallel cultures, and
the density was further decreasing with time of treatment with
Mxt (depth of senescence; Fig. 1). Numerically, when the cell
density in the treated cultures was expressed as a fraction of
that in the untreated ones of the same age (1.00), it was appar-
ent that after exposure to Mxt for 48 and 72 h there were only
0.16 and 0.06 cells at confluence, respectively. Figure 2 illus-
trates the induction of the senescence-associated b-galactosi-
dase activity (37,38) in A549 cells growing in the presence of
Mxt for 72 h. It is quite evident that the b-galactosidase posi-
tive cells are larger and have much lower saturation density on
the slide.
Taking into an account the change in morphology of cells
undergoing senescence revealed by the increased nuclear size
and the remarkable cell ‘‘flattening’’, we expected that the mor-
phometric analysis of the nucleus by LSC would provide a sen-
sitive marker of such a change. Indeed, when the nuclear size
represented by the area of the DNA-associated DAPI fluores-
cence was plotted versus the maximal pixel of DNA/DAPI flu-
orescence on bivariate distribution scatterplots (Fig. 3), it was
apparent that senescent cells in the Mxt-treated cultures had
increased area and distinctly decreased intensity of maximal
pixel of DNA/DAPI fluorescence. As DNA/DAPI area was
increased and the intensity of maximal pixel decreased in
senescent cells, the ratio of maximal pixel to area (mp/area)
was decreased to an even greater degree during treatment with
Mxt and progressively with time. Concurrent analysis of the
integral of intensity of DAPI fluorescence and immunofluores-
cence of p21
WAF1 revealed the arrest in G1 and G2M phases of
Figure 1. Decreased cell saturation density at confluence in cul-
tures of A549 cells growing in the presence of Mxt. The cells we
untreated (Ctrl) or grown in the presence of 2 nM Mxt for 48 or 72
h in chamber slide-cultures. The cells were fixed, stained with
DAPI, and their location on the slides was recorded by LSC
(36,37). The observed decrease in cell density in the Mxt-treated
cultures can be presented as a fraction (index, I) of cell density (I
5 1.00) in the untreated culture of the same age.
Figure 2. Induction of senescence-associated b-galactosidase activity in A549 cells growing for 72 h in the presence of 2 nM Mxt. Images
of cells growing in the absence (A) and presence of Mxt (B) recorded by LSC (Research Imaging Cytometer iCys). Fifty Micrometer bars
mark the length scale.
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expression of p21
WAF1 (Fig. 3). When the initially treated with
2 nM Mxt for 72 h A549 cells were cultured in Mxt-free me-
dium for 10 subsequent days, there was no evidence of forma-
tion of cell colonies (not shown). This observation provided
verification of the loss of their reproductive capability.
As the ratio of intensity of maximal pixel of DAPI fluores-
cence to DAPI area (mp/area) was shown to be a sensitive bio-
marker of cell senescence, we tested the effects of higher con-
centrations of Mxt, shown before to lead to apoptosis rather
than senescence on prolonged treatment in cultures (47). As it
is evident in Figure 4, exposure of A549 cells to 10-fold and
100-fold higher Mxt concentration caused an increase in
expression of p21
WAF1 and some arrest in the cell cycle, but
essentially had no effect on mp/area ratio, which varied
between 0.9 and 1.1.
The induction of cell senescence appears to require cell
cycle arrest and ongoing or even accelerated metabolic activity
(cell growth), particularly ribosome biogenesis that is known
to be mediated by the mammalian target of rapamycin
(mTOR) pathway (48). Therefore, we have tested the ability of
cells to synthesize RNA at Mtx concentration that induced se-
nescence (2 nM) and compared it with Mtx concentration
that did not lead to senescence (20 and 200 nM). As it is evi-
dent from the data shown in Figure 5, incorporation of the
RNA precursor EU, detected by the ‘‘click’’ chemistry method-
ology (42), was suppressed by 52 and 86% in cells treated with
2 and 20 nM Mxt, respectively. The suppression was even
greater at 200 nM concentration of Mxt (not shown).
Although activation of cell growth and metabolic rate
enhances the rate of induction to senescence and ‘‘depth’’ of
senescence, the suppression of growth and of metabolic rate
Figure 4. Effect of Mxt at 20 nM and 200 nM concentration on morphometric features of A549 cells and on p21
WAF1 expression. The cells
were grown in the presence of Mxt for 48 or 72 h; their DNA was stained with DAPI, and p21
WAF1 was detected immunocytochemically.
The ratio of maximal pixel of DAPI fluorescence intensity/nuclear area (mp/area) in the Mxt-treated cells is expressed as a fraction of such
ratio of the untreated cells (Ctrl; 1.0).
Figure 3. LSC-assisted morphometric analysis of nuclear changes and expression of p21
WAF1 of A549 cells in cultures treated with Mxt.
The cells were untreated (Ctrl) or treated with 2 nM Mxt for 24, 48, or 72 h, their DNA was stained with DAPI and p21
WAF1 was detected
immunocytochemically (Alexa 633 indirect Ab). Intensity of maximal (max) pixel of DNA/DAPI reports degree of chromatin condensation
and in untreated cells has the highest value and marks mitotic (M) and immediately postmitotic (pM) cells. In the senescing cells, while nu-
clear area increases, the intensity of maximal pixel decreases likely due to the ‘‘flattening’’ of the cell. The insets in the top left panels show
DNA frequency histograms of cells from the respective cultures. The bar plots at the bottom panels show mean values (standard devia-
tion) of nuclear DNA/DAPI area, DNA/DAPI maximal pixel and the ratio of maximal pixel to nuclear area. The ratio of maximal pixel/nuclear
area of the Mxt-treated cells is expressed as a fraction of such ratio of the respective control (1.0).
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bolite 2dG decreases oxidative phosphorylation and was
shown to lower the constitutive DNA damage response, the re-
porter of DNA damage induced by endogenously generated re-
active species generated during oxidative metabolism (51,52).
We have tested whether the suppression of the cell’s metabolic
rate by 2dG can affect the depth of senescence induced by Mxt
reflected by nuclear morphometry as measured by LSC. As is
show in Figure 6, treatment of A549 cells with Mxt in the pre-
sence of 2dG diminished both the degree of reduction of in-
tensity of maximal pixel fluorescence of DAPI (DNA) and the
decrease of mp/area ratio compared with cell growth in the
presence of Mxt alone. The expression of p21
WAF1 paralleled
the changes in nuclear morphometry showing that the degree
of its induction in cells growing in the presence of Mxt and
2dG was distinctly suppressed compared with cells growing in
the presence of Mxt alone (Fig. 6).
One of the frequently used means of induction of cell se-
nescence involves their growth in the presence of histone dea-
cetylase (HDAC) inhibitors (53,54). Thus, we studied the
effect of exposure of A549 cells to one such inhibitor, TSA, by
measuring the changes in intensity of maximal pixel DNA/
DAPI fluorescence and nuclear area in the cells growing in its
presence (Fig. 7). Consistent with the data on the induction of
senescence of A549 cells by the DNA-damaging drug Mxt (Fig.
3), dramatic reduction in the intensity of the maximal pixel
fluorescence concurrent with the induction of p21
WAF1 and
p27
KIP1 have been seen in cells treated with 0.5 and 1.0 lMo f
TSA. The change in the ratio of mp/area was more pro-
nounced at 1.0 lM (mp/area 5 0.30) than at 0.5 lM (mp/area
5 0.41) concentration of TSA.
As mentioned previously, one of the characteristic fea-
tures of chromatin senescent changes is the presence of SAHF
(23–25). Heterochromatin is a condensed state of chromatin
with DNA more compressed per unit of space compared with
euchromatin. Therefore, one would expect that SAHF may
have increased intensity of maximal pixel of DNA/DAPI fluo-
rescence and the approach we used to identify senescent cells
based on analysis of DAPI/DNA maximal pixel by LSC may
not be applicable to cells with SAHF. The presence of SAHF
was described predominantly in senescing fibroblasts WI-38
(23–25). We have tested whether induction of senescence in
WI-38 cells can be detected by the biomarker based on the in-
tensity of DAPI/DNA maximal pixel. WI-38 cells when treated
with 2 nM Mxt and viewed under the fluorescence microscope
Figure 5. Effect of Mxt at 2 and 20 nM concentration on ability of
A549 cells to synthesize RNA. The cells were untreated (Ctrl) or
treated with 2 and 20 nM Mxt for 4 h, then the RNA precursor EU
was added for 30 min. The incorporation of EU was detected
using a copper (l)-catalyzed cycloaddition reaction (‘‘click’’ chem-
istry) with fluorescent azide (44). The mean fluorescence intensity
for all cells in the Mxt treated cultures is expressed as a fraction of
the mean fluorescence of the untreated cells.
Figure 6. Effect of 2dG on depth of senescence induced by Mxt. A549 cells were grown in the absence (Ctrl) or presence of 2 nM Mxt alone
(Mxt) or 2 nM Mxt and 5 mM 2dG (Mxt 1 2dG) for 72 h. Their DNA was stained with DAPI, and p21
WAF1 was detected immunocytochemi-
cally. Note attenuation of the ratio mp/area and p21
WAF1 in cultures growing in the presence of 2dG compared to Mxt alone.
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presence of SAHF (not shown). However, as it is evident from
the data shown in Figure 8 the senescing WI-38 cells, similar
to A549, show a distinct decrease in intensity of maximal pixel
of DNA/DAPI fluorescence and marked reduction of the mp/
area ratio. Thus, the presence on SAHF does not interfere with
the use of the maximal pixel intensity of DAPI fluorescence as
a marker of cell senescence.
Induction of cell senescence is one of the facets of DNA
damage response, and it provides the barrier preventing tumor
development (9,11–16) as well as impeding formation of
induced-pluripotent stem cells (iPSCs) and potential initiators
of neoplastic transformation (55). Among the early events of
DNA damage response are activation of ATM by its phospho-
rylation on Ser1981 and phosphorylation of histone H2AX on
Ser139, changes that can be detected by and measured by LSC
(56,57). We have tested whether the low (2 nM) concentration
of Mxt that induces cell senescence after 48–96 h of exposure
triggers these early events of DNA damage response. The data
shown in Figure 9 demonstrates that exposure of A549 cells to
2 nM Mxt for only 1 or 2 h caused a distinct increase in the
level of phosphorylation of these proteins. In cells treated with
Mxt for 2 h, the increase in expression of cH2AX and ATM-
S1981P was by 89 and 187%, respectively, above the level of
expression of these phosphoproteins seen in the untreated cells
(Ctrl). The latter represents constitutive phosphorylation of
these proteins that in large part reports DNA damage response
to the damage triggered by endogenous metabolically gener-
ated oxidants (52,57).
DISCUSSION
Induction of senescence of A549 and WI-38 cells has been
studied to explore the analytical capability of LSC for identifica-
tion of senescent cells phenotype and quantitative assessment of
the senescence process. The data obtained by this approach pro-
vided some interesting information. To explain why senescence
was induced at low (1 or 2 nM) but not at higher (20 or 200
nM) concentration of Mxt (Fig. 4), we have measured the abil-
ity of cells to synthesize RNA at these concentrations. The
‘‘click’’ chemistry approach (42) was used to measure incor-
poration of EU by individual cells to be measured by LSC. The
data show that while there was a rather modest attenuation of
RNA synthesis at 2 nM (50%), much more dramatic suppres-
sion was seen at 20 nM ([86%; Fig. 5) and 200 nM ([95%)
Figure 7. Induction of senescence of A549 cells by TSA. The cells were grown in absence (Ctrl) or presence of TSA at 0.5 or 1.0 lM concen-
tration for 48 h. Their DNA was stained with DAPI, expression of p21
WAF1 and p27
KIP1 was detected immunocytochemically and all parame-
ters were measured by LSC.
Figure 8. Induction of senescence of WI-38 cells represented by the decrease in intensity of maximal pixel DAPI fluorescence and mp/area
ratio following treatment with 2 nM Mxt for 4 and 5 days. Bottom panels show saturation density of cells at confluence in the respective
cultures, with I 5 1.0, I 5 0.31 and I 5 0.19 in Ctrl, after 4 and 5 days of treatment with Mxt, respectively.
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notion that ongoing RNA synthesis (cell growth) is needed to
drive the cells toward senescence (49,57–59). When the cell
cycle progression is halted, whether by a DNA damaging drug
(Mxt; Fig. 3) or HDAC (TSA; Fig. 8), cell growth has to con-
tinue for the cells to develop the senescent phenotype (50). In
fact, prolonged maintenance of unbalanced growth caused by
suppression of DNA replication by variety of inhibitors was
shown to lead to development of the senescent phenotype as
well as to upregulation of senescence-associated genes (58).
However, in all the instances of cell cycle arrest, when inhibition
of cell growth rate was attenuated either by: (i) reduction of
protein synthesis or suppression of extracellular signal-regulated
kinase/mitogen-activated protein (ERK/MAP) kinase pathway
(58), (ii) blocking mTOR pathway (49), (iii) inhibition of gly-
colysis by 2dG (Fig. 6), or (iv) caloric restriction (50), the pro-
pensity of cells to undergo senescence was distinctly reduced. In
contrast, oncogene-driven acceleration of growth rate promotes
induction of cell senescence (8,59). The present data are in sup-
port of most of the earlier observations linking cell growth as
an essential event for the induction of senescence of cells that
are arrested in the cell cycle.
The availability of the biomarkers probing cell death is
very much needed both in basic research as well as in clinical
studies. Although there is vast array of different markers of ap-
optotic cells (reviews, refs. 60–62), fewer are available to detect
senescent cells. Particularly, there is a lack of methods that can
quantitatively assess the degree (‘‘depth’’) of cell senescence.
However, it becomes more and more apparent that while apo-
ptosis is common during treatment of leukemias, senescence
is the more predominant mode of death of tumor cells during
treatment of solid tumors. In this study, using the morpho-
metric analytical capabilities of LSC, we describe a simple
approach to measure the alterations in nuclear and chromatin
structure that accompany cell senescence. The observed
decrease in intensity of maximal pixel of DNA/DAPI fluores-
cence and the increase in nuclear area measured by LSC is a
consequence of a change of cell geometry namely its extensive
flattening of the senescent cell. Because the thickness of the
nucleoplasm is diminished compared with the nonsenescent
cell, the intensity of DNA-associated fluorescence (DAPI) per
unit of nuclear image (pixel) also is diminished. Thus, the bio-
marker based on analysis of nuclear area and intensity of max-
imal pixel of DNA-associated fluorescence is a sensitive re-
porter of the characteristic change in cell phenotype consid-
ered to be the hallmark of senescence.
Another attribute of the senescence phenotype, also con-
sidered to be its hallmark, is the low saturation density in cul-
tures at the plateau phase of cell growth. Analysis of cell den-
sity on slides/cultures is provided automatically by LSC and is
routinely plotted on the X-axis versus Y-axis scatterplots (Figs.
1 and 8). Thus, cell densities in cultures suspected to senesce
can be simply compared with the densities of the control cul-
ture of the same age to obtain a quantitative parameter char-
acterizing degree (depth) of quiescence based on analysis of
saturation density at confluency.
Analysis of intensity of maximal pixel of DNA-associated
(DAPI) fluorescence and nuclear area, especially when
expressed as a ratio of mp/area, made it possible not only to
identify senescent cells but also provides the means to express
and compare the degree (depth) of senescence in quantitative
terms. This has been done by normalizing (standardizing) the
change in nuclear morphometry in senescing cells through
expressing this as a fraction of such ratio of the respective
nonsenescent control cells. We have used this approach to
compare and quantify the effect of treating cells for different
lengths of time and to different concentrations of inducers or
inhibitors of cell senescence.
Taking advantage of multiparameter and multispectral
analysis provided by LSC (iCys Research Imaging Cytometer),
which has three-color laser illumination and four channels of
fluorescence measurement, the morphometric nuclear changes
(maximal pixel and area) were measured in parallel with anal-
ysis of the induction of p21
WAF1 and p27
KIP1. As a result, it
was possible to measure the correlation between the morpho-
metric nuclear change and the expression of these CDK inhibi-
tors on a cell by cell basis as well as to measure other attributes
of the cell and to correlate them with the senescence biomar-
ker. It should be noted that measurement of fluorescence in-
tensity by LSC is accomplished with photomultipliers that
Figure 9. Early events of DNA damage response marked by induction of cH2AX and phosphorylation of ATM on Ser1981 (ATM
P) after
treatment of A549 cells with 2nM Mxt for 1 or 2 h. The index I represents the level of induction of cH2AX and ATM-S1981
P markers in Mxt-
treated cells related to their constitutive level in the untreated (Ctrl) cells (I 5 1.00).
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ment, exceeding that of image analyzers that use charge-
coupled device cameras (39–41).
CONCLUSIONS
Organismal aging is a consequence of individual cells
undergoing senescence. The induction of cell senescence
appears also to be the critical mode of cell death in solid
tumors during chemotherapy or radiotherapy. Cell senescence
is also a key element of the tumor suppressor pathways includ-
ing the pathway modulating formation of the iPSCs (55,63).
Therefore, there is a need for quantitative biomarkers that can
be used to assess cell senescence in vitro and in vivo. This data
demonstrate that morphometric analysis of cellular attributes
by LSC offers an attractive tool to detect cell senescence and
measure its degree particularly in assessing the factors acceler-
ating or delaying this process. By relying on analysis of change
in geometry of cell nucleus and spatial distribution of DNA in
chromatin, this approach may provide a sensitive biomarker
that has a potential to be used on biopsy- and tissue section-
specimens.
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